J&J Zarnestra R&D (correction)
Executive Summary
J&J's Zarnestra R&D will be overseen by Pharmaceutical Research & Development unit, not Ortho Oncology Specialty & Therapeutics, as reported in "The Pink Sheet" (July 21, p. 29). The newly formed oncology and HIV unit will direct commercial activities for Zarnestra (R115777)...
J&J's Zarnestra R&D will be overseen by Pharmaceutical Research & Development unit, not Ortho Oncology Specialty & Therapeutics, as reported in "The Pink Sheet" (July 21, p. 29). The newly formed oncology and HIV unit will direct commercial activities for Zarnestra (R115777).... |